WDR45 - WD Repeat Domain 45
Introduction
Pathway Diagram
flowchart TD
WDR45["WDR45"]
BECN1["BECN1"]
PIK3C3["PIK3C3"]
UVRAG["UVRAG"]
AMBRA1["AMBRA1"]
MAP1LC3B["MAP1LC3B"]
MTOR["MTOR"]
AUTOPHAGY["Autophagy"]
HDAC6["HDAC6"]
APP["APP"]
PSEN1["PSEN1"]
COASY["COASY"]
FA2H["FA2H"]
NEURODEGENERATION["Neurodegeneration"]
PARKINSON["Parkinson Disease"]
WDR45 -->|"forms complex"| BECN1
BECN1 -->|"interacts"| PIK3C3
PIK3C3 -->|"initiates"| AUTOPHAGY
WDR45 -->|"regulates"| UVRAG
WDR45 -->|"associates"| AMBRA1
UVRAG -->|"promotes"| AUTOPHAGY
AMBRA1 -->|"enhances"| AUTOPHAGY
AUTOPHAGY -->|"processes"| MAP1LC3B
MTOR -->|"inhibits"| AUTOPHAGY
WDR45 -->|"dysfunction impairs"| AUTOPHAGY
HDAC6 -->|"regulates"| AUTOPHAGY
APP -->|"processed by"| AUTOPHAGY
PSEN1 -->|"interacts"| APP
COASY -->|"lipid metabolism"| NEURODEGENERATION
FA2H -->|"fatty acid metabolism"| NEURODEGENERATION
AUTOPHAGY -->|"dysfunction causes"| NEURODEGENERATION
NEURODEGENERATION -->|"manifests as"| PARKINSON
classDef central fill:#006494,color:#e0e0e0
classDef protective fill:#1b5e20,color:#e0e0e0
classDef pathological fill:#ef5350,color:#0d0d1a
classDef regulatory fill:#4a1a6b,color:#e0e0e0
classDef outcome fill:#5d4400,color:#e0e0e0
class WDR45 central
class BECN1,PIK3C3,UVRAG,AMBRA1,AUTOPHAGY protective
class APP,PSEN1 pathological
class MTOR,HDAC6 regulatory
class NEURODEGENERATION,PARKINSON outcome
...WDR45 - WD Repeat Domain 45
Introduction
Pathway Diagram
Mermaid diagram (expand to render)
Wdr45 Wd Repeat Domain 45 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> [@saitsu2013]
<div class="infobox-header">WDR45 Gene</div> [@liu2020]
<div class="infobox-content"> [@gregory2019]
Official Symbol: WDR45<br/>
Full Name: WD Repeat Domain 45<br/>
Chromosomal Location: Xp11.23<br/>
NCBI Gene ID: 11152<br/>
OMIM: 300526<br/>
Ensembl ID: ENSG00000196998<br/>
UniProt: Q9Y5X9<br/>
Associated Diseases: Neurodegeneration with Brain Iron Accumulation Type 1 (NBIA1), Static Encephalopathy of Childhood with Neurodegeneration in Adulthood (SENDA), Rett Syndrome
</div>
</div>
Overview
WDR45 encodes a WD repeat protein involved in autophagy and early iron metabolism. Mutations cause a form of neurodegeneration with brain iron accumulation (NBIA) characterized by progressive neurological deficits.
Normal Function
WDR45 (also called WIPR1) participates in autophagy:
- Autophagosome Formation: Required for proper autophagosome biogenesis
- Iron Metabolism: Regulates cellular iron homeostasis
- Lysosomal Function: Coordinates with the autophagy-lysosomal pathway
- Protein Quality Control: Facilitates clearance of damaged organelles
- Neuroprotection: Protects against oxidative stress
The protein contains WD40 repeats that form a beta-propeller structure.
Disease Associations
Neurodegeneration with Brain Iron Accumulation Type 1 (NBIA1)
WDR45 mutations cause X-linked NBIA:
- Progressive parkinsonism and dystonia
- Iron accumulation in globus pallidus and substantia nigra
- Cognitive decline
- Seizures in some cases
- Typically affects males; heterozygous females may be carriers
SENDA Syndrome
Static Encephalopathy of Childhood with Neurodegeneration in Adulthood:
- Initial static encephalopathy in childhood
- Neurodegenerative course in adulthood
- Progressive dystonia and parkinsonism
- Iron deposition on brain MRI
Rett Syndrome
WDR45 variants have been reported in Rett-like syndrome:
- Developmental regression
- Hand-wringing movements
- Seizures
- Autonomic dysfunction
Expression Pattern
WDR45 is expressed in neuronal tissues:
- Brain (cerebral [cortex](/brain-regions/cortex), cerebellum)
- Substantia nigra
- Globus pallidus
- Spinal cord
Cytoplasmic and punctate staining pattern consistent with autophagosomal localization.
Therapeutic Targeting
| Strategy | Approach | Status |
|----------|----------|--------|
| Iron Chelation | Deferoxamine, deferasirox | Standard of care |
| [Autophagy](/entities/autophagy) Modulation | [mTOR](/entities/mtor) inhibitors, rapamycin | Research |
| Gene Therapy | AAV-delivered wild-type WDR45 | Preclinical |
| Neuroprotective Agents | Antioxidants | Supportive care |
Key Publications
Haack TB, et al. (2012). "Exome sequencing identifies WDR45 mutations." American Journal of Human Genetics. PMID: 22677156(https://pubmed.ncbi.nlm.nih.gov/22677156/).[@haack2012]
Saitsu H, et al. (2013). "WDR45 mutations in NBIA and SENDA." Nature Genetics. PMID: 23542699(https://pubmed.ncbi.nlm.nih.gov/23542699/).[@saitsu2013]
Liu Y, et al. (2020). "WDR45 and autophagy in neurodegeneration." Journal of Molecular Neuroscience. PMID: 32062731(https://pubmed.ncbi.nlm.nih.gov/32062731/).[@liu2020]
Gregory A, et al. (2019). "WDR45-related NBIA." GeneReviews. PMID: 31692426(https://pubmed.ncbi.nlm.nih.gov/31692426/).[@gregory2019]See Also
- [Neurodegeneration with Brain Iron Accumulation](/diseases/nbia)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Dystonia](/diseases/dystonia)
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
- [Iron Homeostasis](/mechanisms/iron-homeostasis-neurodegeneration)
- [PANK2 Gene](/proteins/pank2-protein)
- [COA5 Gene](/coa5-gene)
External Links
- [NCBI Gene: WDR45](https://www.ncbi.nlm.nih.gov/gene/11152)
- [UniProt: WDR45](https://www.uniprot.org/uniprot/Q9Y5X9)
- [OMIM: WDR45](https://www.omim.org/entry/300526)
- [Allen Brain Atlas: WDR45 Expression](https://human.brain-map.org/microarray/search/show?search_term=WDR45)
Background
The study of Wdr45 Wd Repeat Domain 45 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Molecular Mechanisms
WD40 Repeat Structure
WDR45 contains WD40 repeat domains that form a beta-propeller structure[@gregory2019]:
- Propeller Architecture: Seven blades forming a circular beta-propeller
- Protein-Protein Interactions: Surface residues mediate protein binding
- Scaffold Function: Provides platform for complex assembly
- Cellular Localization: Predominantly cytoplasmic with nuclear presence
Role in Autophagosome Biogenesis
WDR45 functions at multiple stages of autophagy[^5]:
Initiation: Participates in PI3K complex recruitment
Nucleation: Assists in isolation membrane formation
Elongation: Coordinates with ATG proteins for autophagosome expansion
Closure: Helps complete autophagosome formation
Maturation: Regulates fusion with lysosomesWDR45 connects autophagy to iron homeostasis:
- Ferritinophagy: Selective autophagy of iron-containing ferritin
- Iron Release: Autophagy-dependent iron release from stores
- Oxidative Stress: Iron dysregulation increases ROS production
- Mitochondrial Function: Iron-sulfur cluster assembly
Clinical Features
NBIA1 Phenotype
Neurodegeneration with Brain Iron Accumulation Type 1:
Core Features:
- Progressive dystonia and parkinsonism
- Iron accumulation in globus pallidus
- Cognitive decline (variable)
- Speech difficulties (dysarthria)
- Gait abnormalities
Disease Progression:
- Childhood onset (variable)
- Progressive motor decline
- Eventual loss of ambulation
- Cognitive impairment in later stages
SENDA Syndrome
Static Encephalopathy of Childhood with Neurodegeneration in Adulthood:
- Normal early development
- Learning difficulties in childhood
- Neurodegeneration beginning in adolescence/young adulthood
- Iron accumulation later in disease course
Diagnosis
MRI Findings
- T2 Hypointensity: Iron deposition in globus pallidus
- Swallow Tail Sign: Loss of substantia nigra "swallow tail"
- White Matter Changes: Variable white matter abnormalities
- Atrophy: Progressive brain volume loss
Genetic Testing
- Sequencing: WDR45 gene sequencing
- Deletion Analysis: Copy number variants
- Carrier Testing: For family planning
- Prenatal Testing: For known family mutations
Treatment Approaches
Symptomatic Management
- Dystonia Treatment: Botulinum toxin, oral medications
- Parkinsonism: Dopaminergic agents (variable response)
- Seizure Control: Antiepileptic drugs as needed
- Supportive Care: Physical therapy, occupational therapy
Disease-Modifying Strategies
- Iron Chelation: Deferoxamine, deferasirox (controversial benefit)
- Autophagy Enhancement: sirolimus (rapamycin) trials
- Coenzyme Q10: Mitochondrial support
- Neuroprotective Agents: Under investigation
Experimental Approaches
- Gene Therapy: Viral vector delivery of functional WDR45
- Small Molecule Enhancers: Autophagy-promoting compounds
- Iron Metabolism Modulators: Novel chelation strategies
Research Models
Cellular Models
- Patient Fibroblasts: Show autophagy defects
- iPSC-derived Neurons: Disease modeling
- Knockout Cells: CRISPR models of deficiency
Animal Models
- Mouse Models: Wdr45 knockout shows iron accumulation
- Zebrafish: Developmental studies
- Drosophila: Genetic interaction studies
Summary
WDR45 is essential for autophagy and iron metabolism. Mutations cause NBIA1 and SENDA syndrome, characterized by brain iron accumulation and progressive neurodegeneration. Understanding WDR45 function provides insights into autophagy-iron relationships and potential therapeutic targets.
References
[Haack TB, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22677156/)
[Saitsu H, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23542699/)
[Liu Y, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32062731/)
[Gregory A, et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31692426/)Pathway Diagram
The following diagram shows the key molecular relationships involving WDR45 - WD Repeat Domain 45 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)